Renal angiomyolipoma (AML) is a benign tumor. However, rare cases of renal AML demonstrate aggressive behaviors such as tumor thrombus extension into the inferior vena cava (IVC). We successfully treated a case of epithelioid AML in the right kidney involving the IVC. We also reviewed and analyzed 45 case reports of the common type of AML. Radiologists and clinicians should know that epithelioid AML can be an aggressive tumor.

Keywords:
Angiomyolipoma, Tumor thrombus, Inferior vena cava
1.
Yip KH, Peh WC, Tam PC: Spontaneous rupture of renal tumours: the role of imaging in diagnosis and management. Br J Radiol 1998;71:146-154.
2.
Wilson SS, Clark PE, Stein JP: Angiomyolipoma with vena caval extension. Urology 2002;60:695-696.
3.
Eble JN, Sauter G, Epsstein JI, et al: World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon, IARC Press, 2004, pp 65-69.
4.
Tsai CC, Wu WJ, Li CC, Wang CJ, Wu CH, Wu CC: Epithelioid angiomyolipoma of the kidney mimicking renal cell carcinoma: a clinicopathologic analysis of cases and literature review. Kaohsiung J Med Sci 2009;25:133-140.
5.
Nelson CP, Sanda MG: Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002;168:1315-1325.
6.
Takebayashi S, Hidai H: Renal angiomyolipoma extending into the renal vein: axial CT and virtual CT intravascular endoscopic images. Eur J Radiol Extra 2008;68:25-28.
7.
Kutcher R, Rosenblatt R, Mitsudo SM, Goldman M, Kogan S: Renal angiomyolipoma with sonographic demonstration of extension into the inferior vena cava. Radiology 1982;143:755-756.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.